Terry Rudd

Clinical Topics & News Publish date: April 22, 2020 Understanding the hormonal changes women go through over their lives can help physicians refine migraine treatment approaches. “It’s so critical that you know what’s going on hormonally, both endogenously and exogenously, to better evaluate treatment,” according to Susan Hutchinson, MD, director of the Orange County Migraine & Headache Center in Irvine, Calif. In an interview, Alan M.

Video Publish date: April 17, 2020 CGRP receptor agonists to treat migraine don’t boost stroke risk, but they could worsen stroke outcomes, according to a new animal study. “It turns out that these drugs make the blood vessels of the brain dysfunctional, such that the collateral channels that bring in blood to the region that is having the stroke are impaired,” explains the study’s lead author, Cenk Ayata, MD, associate professor of neurology and radiology at Harvard Medical School, Boston.

Latest News Publish date: March 26, 2020 Author(s): Terry Rudd MDedge News What can the nation’s critical care systems do to prepare for the worst of the COVID-19 pandemic? Mark Tonelli, MD, is professor of medicine and section head of the University of Washington Medical Center’s division of pulmonary, critical care, and sleep medicine.